10th Intl Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Cascais, London, UK Nov 6-8 2008

Conference Reports for NATAP


10th Intl Workshop on Adverse Drug Reactions and Lipodystrophy in HIV London, UK Nov 6-8 2008

	Webcasts from the 10th Intl Workshop on Adverse Drug Reactions & Lipodystrophy Report from the 10th Intl Workshop on Adverse Drug Reactions and Lipodystrophy in HIV - written by Michael Dube, MD - (12/13/08) A Comparison of Cardiac Function Between HIV-Infected and HIV-Seronegative People With and Without the Metabolic Syndrome. - (12/10/08) COMPARISON OF THE EFFECTS OF NEVIRAPINE RESPECT TO EFAVIRENZ ON DIFFERENTIATING AND MATURE HUMAN ADIPOCYTES IN CULTURE -s (12/10/08) Continuous Antiretroviral Therapy Decreases Bone Mineral Density: Results from the SMART Study (11/24/08) Bone Loss in SMART Study - Written by Mark Mascolini - (10/30/08) Effect of HAART on insulin sensitivity, autonomic nervous system function and beta-adrenergic mediated lipolysis (11/20/08) Efavirenz induces alterations in lipid metabolism through AMPK activation (11/20/08) COMPARISON OF THE EFFECTS OF LOPINAVIR/RITONAVIR AND EFAVIRENZ ON GENE EXPRESSION AND DIFFERENTIATION OF HUMAN ADIPOCYTES (11/20/08) Impact of body changes on the quality of life of HIV-positive treatment experienced patients An online community-based survey (11/10/08) Skeletal muscle mitochondrial proteins discordantly regulated by insulin in HIV+ with insulin resistance: a mass spectrometry-based muscle proteomics study (11/10/08) Association between Peripheral Lipoatrophy and Bone Demineralisation in Treated HIV-positive Males (11/10/08) Effect of Tesamorelin (TH9507), a Growth Hormone-Releasing Factor (GRF) Analogue, on Visceral Adipose Tissue (VAT) in HIV-Infected Patients with Excess Abdominal Fat: Impact of Antiretroviral Therapy Regimen (11/10/08) CD4 and Undetectable Viral Load Predict Non-AIDS Cancers: "AIDS and non-AIDS defining malignancies in HIV-infected patients - The 2006 ONCOVIH French study" (11/10/08) Comparison of Directly Measured and Estimated Glomerular Filtration Rates in Virologically Suppressed Patients Switching to Tenofovir or Continuing Zidovudine (11/10/08)